Cell cycle proteins and retinal degeneration: Evidences of new potential therapeutic targets

7Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

During different forms of neurodegenerative diseases, including the retinal degeneration, several cell cycle proteins are expressed in the dying neurons from Drosophila to human revealing that these proteins are a hallmark of neuronal degeneration. This is true for animal models of Alzheimer’s, and Parkinson’s diseases, Amyotrophic Lateral Sclerosis and for Retinitis Pigmentosa as well as for acute injuries such as stroke and light damage. Longitudinal investigation and loss-of-function studies attest that cell cycle proteins participate to the process of cell death although with different impacts, depending on the disease. In the retina, inhibition of cell cycle protein action can result to massive protection. Nonetheless, the dissection of the molecular mechanisms of neuronal cell death is necessary to develop adapted therapeutic tools to efficiently protect photoreceptors as well as other neuron types.

Cite

CITATION STYLE

APA

Arsenijevic, Y. (2016). Cell cycle proteins and retinal degeneration: Evidences of new potential therapeutic targets. In Advances in Experimental Medicine and Biology (Vol. 854, pp. 371–377). Springer New York LLC. https://doi.org/10.1007/978-3-319-17121-0_49

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free